Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 4/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16468420 | 0.89 | L3MBTL1 (0.43) | L3MBTL1LMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL16467924 | 0.89 | L3MBTL1 (0.43) | L3MBTL1LMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL16467889 | 0.86 | HTT (0.43) | L3MBTL1LMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL16468501 | 0.83 | CHRNB2 (0.48) | L3MBTL1MEN1KMT2ASMN1; SMN2HTT | |
| SCHEMBL16467913 | 0.83 | ALDH1A1 (0.48) | L3MBTL1LMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL2596250 | 0.83 | ALDH1A1 (0.42) | L3MBTL1LMNASMN1; SMN2HTTALDH1A1 | |
| SCHEMBL16467938 | 0.82 | L3MBTL1 (0.41) | L3MBTL1LMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL16468152 | 0.78 | KMT2A (0.48) | L3MBTL1LMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL16467928 | 0.78 | KMT2A (0.46) | L3MBTL1LMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL16467904 | 0.75 | MAPT (0.48) | L3MBTL1LMNAMEN1KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150051257-A1 | SULPHONAMIDE DERIVATIVES OF BENZYLAMINE FOR THE TREATMENT OF CNS DISEASES | ADAMED SP. ZO.O (PL) | 2015-02-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150051257-A1 | SULPHONAMIDE DERIVATIVES OF BENZYLAMINE FOR THE TREATMENT OF CNS DISEASES | AQP4, BCL6, STS | L3MBTL1 1649/4885LMNA 3042/4885MEN1 2136/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.